home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Webinar On FDA vs EU Inspections – Differences and How to Get Prepared

 
  November 10, 2015  
     
 


Compliance Trainings, Online
2015-12-03


Description :

This training is a comparative look at FDA & EU regulations to help attendees understand the FDA and EU inspection process and how to prepare for both of them. Attendees will learn the best practices to respond to Form 483 citations, Warning Letters and EU inspection findings.

FDA and EU GCP regulations and standards apply pharmaceuticals, biologics and medical devices. Failure to conform to these requirements may result in concerns about quality and integrity. Inspections are critical to the success of business on several levels. Therefore, being appropriately prepared and management of the inspection and audit process are critical activity. The consequences if a company does not pass an inspection are time consuming, delayed product approvals, and could lead to civil or even criminal litigation by the FDA and EU inspection agencies.

This webinar has been specifically designed to help attendees prepare for FDA and EU inspection. It will provide a background and understanding of the role played by the regulatory inspectors, and the administrative and enforcement powers. Attendees will be taken through the key stages of FDA and EU inspection processes and understands the various types of inspections that can be carried out.

Areas Covered in the Session :

Differences between FDA and EU Inspections including the FDA and EU joint inspection programmer

How to prepare for EMA and FDA audit

How to plan for an audit or inspection using checklists/ FDA/EMEA inspection guidelines

Tips for employees before the inspect

Tips on proper responses to prepare for audit/inspection Interviews

Setting up a Triage to ensure that required documents are available

How to interact with the inspectors—DO's and DON’Ts

How to reply to inspection reports, 483’s and EU inspection finding

Post inspection actions – implementing appropriate CAPAs in response to audit findings

Who Will Benefit:

Quality Assurance Managers

Quality Auditors

Regulatory Affairs Teams

Document Management Teams

 

Professionals who want to know more about inspection guidelines

 
 
Organized by: Compliance Trainings
Invited Speakers:

Marie Dorat, CQA,CAA is a QA/RA compliance, and Training Consultant in the Pharmaceutical/Medical Device & IVD Industry. She is the CEO of IPRF, LLC which specializes in helping established and start-up companies develop and/or update their quality management systems. IPRF also assists companies process the necessary documents for international product distribution.

 
Deadline for Abstracts: 2015-12-03
 
Registration:

For more information about this event please visit

 

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1645

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.